These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35602377)

  • 1. Management of Psychiatric Disorders in Patients with Parkinson's Diseases.
    Tripathi A; Gupta PK; Bansal T
    Indian J Psychiatry; 2022 Mar; 64(Suppl 2):S330-S343. PubMed ID: 35602377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of psychosis and dementia in Parkinson's disease.
    Goldman JG; Holden S
    Curr Treat Options Neurol; 2014 Mar; 16(3):281. PubMed ID: 24464490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychiatric aspects of Parkinson's disease.
    Grover S; Somaiya M; Kumar S; Avasthi A
    J Neurosci Rural Pract; 2015 Jan; 6(1):65-76. PubMed ID: 25552854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric Manifestation in Patients with Parkinson's Disease.
    Han JW; Ahn YD; Kim WS; Shin CM; Jeong SJ; Song YS; Bae YJ; Kim JM
    J Korean Med Sci; 2018 Nov; 33(47):e300. PubMed ID: 30450025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuropsychiatric manifestations in Parkinson's disease].
    Oikonomou E; Paparrigopoulos T
    Psychiatriki; 2015; 26(2):116-30. PubMed ID: 26197101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New pharmacological options for treating advanced Parkinson's disease.
    Devos D; Moreau C; Dujardin K; Cabantchik I; Defebvre L; Bordet R
    Clin Ther; 2013 Oct; 35(10):1640-52. PubMed ID: 24011636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson's Disease?
    Houeto JL; Magnard R; Dalley JW; Belin D; Carnicella S
    Front Psychiatry; 2016; 7():91. PubMed ID: 27303314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric syndromes in Parkinson's disease.
    Starkstein SE; Brockman S; Hayhow BD
    Curr Opin Psychiatry; 2012 Nov; 25(6):468-72. PubMed ID: 22992542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural and behavioral substrates of subtypes of Parkinson's disease.
    Moustafa AA; Poletti M
    Front Syst Neurosci; 2013 Dec; 7():117. PubMed ID: 24399940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and management of the non-motor features of Parkinson's disease.
    Wishart S; Macphee GJ
    Ther Adv Chronic Dis; 2011 Mar; 2(2):69-85. PubMed ID: 23251743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment for cognitive and neuropsychiatric non-motor symptoms in Parkinson's disease: current evidence and future perspectives.
    Mantovani E; Zucchella C; Argyriou AA; Tamburin S
    Expert Rev Neurother; 2023 Jan; 23(1):25-43. PubMed ID: 36701529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease.
    D'Iorio A; Vitale C; Piscopo F; Baiano C; Falanga AP; Longo K; Amboni M; Barone P; Santangelo G
    Parkinsonism Relat Disord; 2017 Oct; 43():114-117. PubMed ID: 28797564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.
    Meltzer HY; Mills R; Revell S; Williams H; Johnson A; Bahr D; Friedman JH
    Neuropsychopharmacology; 2010 Mar; 35(4):881-92. PubMed ID: 19907417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Stage-Based Approach to Therapy in Parkinson's Disease.
    Carrarini C; Russo M; Dono F; Di Pietro M; Rispoli MG; Di Stefano V; Ferri L; Barbone F; Vitale M; Thomas A; Sensi SL; Onofrj M; Bonanni L
    Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31434341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis in Parkinson's disease without dementia: common and comorbid with other non-motor symptoms.
    Lee AH; Weintraub D
    Mov Disord; 2012 Jun; 27(7):858-63. PubMed ID: 22674352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostics and treatment of impulse control disorders, psychosis and delirium: systemic review-based recommendations - guideline "Parkinson's disease" of the German Society of Neurology.
    Witt K; Levin J; van Eimeren T; Hasan A; Ebersbach G;
    J Neurol; 2024 Jul; ():. PubMed ID: 39046524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychiatric issues in cognitive impairment.
    Aarsland D; Taylor JP; Weintraub D
    Mov Disord; 2014 Apr; 29(5):651-62. PubMed ID: 24757113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical overview of non-motor symptoms in Parkinson's Disease.
    Modugno N; Lena F; Di Biasio F; Cerrone G; Ruggieri S; Fornai F
    Arch Ital Biol; 2013 Dec; 151(4):148-68. PubMed ID: 24873924
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.